Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome
Neurogastroenterology & Motility · 2025
DOI: 10.1111/nmo.14984 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neurogastroenterology & Motility, 2025. Verfasst von Per Venge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Uppsala University and Diagnostics Development, Uppsala, Sweden. Hauptthemen laut MEDLINE: Colon, Epithelial Cells, Feces, Intestinal Mucosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Irritable bowel syndrome (IBS) is a common functional gastro‐intestinal disorder characterized by discomfort with constipation and/or diarrhea with unclear pathophysiology. We aimed to determine the activities of colorectal eosinophils, neutrophils and epithelial cells by biomarkers in feces reflecting these activities.
Methods
Fecal samples were collected from 185 patients with IBS before and after 8 weeks of placebo or mesalazine treatment and from 40 healthy subjects. Calprotectin, eosinophil derived neurotoxin (EDN), eosinophil cationic protein (ECP), human neutrophil lipocalin (HNL) (pab/765) or dimer, human phospholipase BII‐precursor (HPLBII‐P) and myeloperoxidase (MPO) were measured by ELISA. Symptom scores were evaluated by diaries.
Results
HPLBII‐P, HNL (pab/765) and EDN, proteins secreted by intestinal epithelial cells, were elevated in IBS patients as compared to healthy subjects ( p < 0.0001– p = 0.008). In contrast, the neutrophil proteins calprotectin, MPO and HNL dimer were unaltered. The eosinophilic protein ECP was lower in IBS ( p = 0.001). HNL (pab/765) ( p = 0.01) and EDN ( p = 0.004) increased in IBS patients after mesalazine treatment. Colo‐rectal mucosa showed strong staining of HPLBII‐P and western blotting of fecal extracts showed the presence of mainly monomeric, epithelial‐associated HNL.
Conclusions
The absence of signs of involvement of neutrophils and eosinophils in IBS suggests that activity of local epithelial cells rather than inflammation may be a major determinant of the disease. The measurements of EDN, HNL (pab/765), and HPLBII‐P may serve as potential fecal biomarkers in the study and monitoring of IBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Uppsala University and Diagnostics Development, Uppsala, Sweden.
- Diagnostics Development, Uppsala, Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Center for Functional GI and Motility Disorders, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Per Venge, Hans Törnblom
Zitieren
APA
Venge, P., Tejera, V. C., Petersson, C., Xu, S., Larsson, A., Simrén, M., Öhman, L., & Törnblom, H. (2025). Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14984
Vancouver
Venge P, Tejera VC, Petersson C, Xu S, Larsson A, Simrén M, et al. Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.14984
BibTeX
@article{Venge2025,
author = {Venge, Per and Tejera, Valeria Castro and Petersson, Christer and Xu, Shengyuan and Larsson, Anders and Simrén, Magnus and Öhman, Lena and Törnblom, Hans},
title = {Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome},
journal = {Neurogastroenterology & Motility},
year = {2025},
doi = {10.1111/nmo.14984}
}
EUVIMED